AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE500.05-1.25 (-0.25 %)
PREV CLOSE ( ) 501.30
OPEN PRICE ( ) 494.85
BID PRICE (QTY) 500.05 (232)
OFFER PRICE (QTY) 500.30 (28)
VOLUME 9469
TODAY'S LOW / HIGH ( )494.85 504.30
52 WK LOW / HIGH ( )408.95 645
NSE500.15-0.6 (-0.12 %)
PREV CLOSE( ) 500.75
OPEN PRICE ( ) 499.00
BID PRICE (QTY) 500.10 (57)
OFFER PRICE (QTY) 500.15 (338)
VOLUME 65550
TODAY'S LOW / HIGH( ) 498.55 504.30
52 WK LOW / HIGH ( )409 645.75

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.